Home › Soft Tissue Sarcoma › Illinois
Soft Tissue Sarcoma clinical trials in Illinois
9 studies for Soft Tissue Sarcoma are looking for participants at sites in Illinois.
Cities in Illinois
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
- Ann & Robert H. Lurie Children's Hospital, Chicago
RecruitingPhase 1
Ages 6 to 17 · All sexes · Updated Nov 12, 2026 · NCT06235125Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
- University of Chicago Comprehensive Cancer Center, Chicago
- UC Comprehensive Cancer Center at Silver Cross, New Lenox
- University of Chicago Medicine-Orland Park, Orland Park
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05711615A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
- Northwestern University, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06942442DESTINY-PANTUMOUR04
- Research Site, Decatur
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- University Chicago Medicine, Chicago
- Carle Cancer Center, Urbana
- Midwestern Regional Medical Center, City of Hope Chicago, Zion
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Lurie Children's Hospital of Chicago, Chicago
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- University of Chicago, Chicago
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 80 · Women · Updated Feb 28, 2025 · NCT00005095From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.